Climate Change Data

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

• The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry, including, but not limited to, development by competitors of new technological innovations, protection of proprietary technology, dependence on key personnel, reliance on single-source vendors and collaborators, availability of raw materials, patentability of the Company’s products and processes and clinical efficacy and safety of the Company’s products under development, compliance with government regulations and the need to obtain additional financing to fund operations.
• The Company’s ability to continue as a going concern is dependent upon its ability to generate revenue and obtain adequate financing.

Mitigation Strategies

• The Company is exploring long-term manufacturing alliances with a number of potential partners to investigate manufacturing processes in order to produce materials at reasonable scale and cost of goods to support future commercialization efforts.
• The Company is exploring partnership opportunities with global biopharmaceutical companies

Supply Chain Management

Climate-Related Risks & Opportunities